Pfizer Animal Health offers grants for swine antibiotic research

$100,000 in grant funding available to study DRAXXIN® for treatment of swine respiratory disease

Friday 5 October 2012 (6 years 5 months 16 days ago)

Pfizer Animal HealthPfizer Animal Health is seeking research proposals to support the continued study of the clinical efficacy of DRAXXIN® (tulathromycin) Injectable Solution, a macrolide for the treatment of swine respiratory disease (SRD), the leading cause of swine mortality in the U.S.

Pfizer Animal Health will provide up to four grants, $100,000 in total, for clinical research on the use of DRAXXIN as part of an overall disease treatment and control plan that demonstrates a direct benefit to swine health. DRAXXIN will be provided to study investigators at no cost.

"DRAXXIN has consistently proven to be an effective tool in swine health management," said Shelley Stanford, DVM, MS, MBA, director, U.S. Pork Technical Services at Pfizer. "Through these research grants, we are seeking to further our understanding of DRAXXIN's real world efficacy and its practical uses."

The deadline for submission of grant proposals is November 15, 2012. Proposals are only being accepted electronically. All applicants must be current university staff, advanced study students at universities or practicing doctors of veterinary medicine. Proposals will be evaluated on their direct clinical applicability, the potential to enhance the treatment of pigs, relevance to existing scientific knowledge and practical study feasibility.

Complete criteria and proposal requirements can be found at A Pfizer Animal Health committee will review applications and alert recipients in December 2012.

Approved in the U.S. in 2005, DRAXXIN treats the five most common bacterial causes of SRD, including mycoplasma hyopneumoniae, and controls SRD associated with three bacterial causes in groups of pigs where SRD has been diagnosed. Its one-dose formula provides nine days of extended therapy and effectiveness while minimizing labor. DRAXXIN also helps reduce shedding, which decreases disease transmission and mortality.

For more information about the swine antibiotic research grants contact Nyota Wright at or 973-660-6908.

Important Safety Information: The pre-slaughter withdrawal time for DRAXXIN in swine is five days. DRAXXIN should not be used in animals known to be hypersensitive to the product.

October 4, 2012 - Pfizer Animal Health

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

Not a registered user of 333?sign upand access swine prices, the search engine, ...
It is fast and free
Are you registered in 333?LOGINIf you've forgotten your password we'll send it to you here